Journal of labelled compounds and radiopharmaceuticals p. 595 - 605 (1996)
Update date:2022-09-26
Topics:
Waterhouse, Rikki N.
Collier, T. Lee
O'Brien
[123I]-1-(2-Hydroxyethyl)-4-(4-iodophenoxymethyl)piperidine has been prepared as a novel sigma receptor radioligand for tumour imaging by SPECT. This ligand was found to be selective in vitro for the sigma-1 receptor (Ki = 2.3 nM) when tested in a variety of neuroreceptor binding assays. The lipophilicity of this ligand is appropriate for crossing the blood/brain barrier (log P7.5 = 4.0). Radioiodination was accomplished by no-carrier- added iododestannylation using chloramine-T in acetic acid. The specific activity of the radiotracer >10,000 mCi/μmole. The radiochemical yield was 63-77% EOS and the radiochemical purity was >99%.
View MoreShanghai Balmxy Pharmaceutical Co., Ltd
Contact:0086-21-24206007
Address:Room 402, 15#, No. 909 wangyue Road, shanghai, P. R. China
Contact:86-513-84128750/13773795976
Address:No.48.Youyi West Road ,Rudong Development Zone,Jiangsu Province,China
Contact:0086-22-23410962
Address:17-201, Ningfuli, Shuishanggongyuandong road,Nankai district, Tianjin, China
Nanjing Habo Medical Technology Co., Ltd.
Contact:025-85769882
Address:No.108. Ganjiabian east. Qixia District .Nanjing
Chengdu NoVi Biotechnology Co., Ltd.(expird)
Contact:13551243286/028-81458053
Address:NO.168-1-224 JULONG ROAD WUHOU DISTRICT, CHENGDU CITY,SICHUAN PROVINCE
Doi:10.1007/BF00903131
(1962)Doi:10.1016/0040-4039(96)01192-6
(1996)Doi:10.1021/jo960852a
(1996)Doi:10.1002/ejoc.201900185
(2019)Doi:10.1021/jacs.0c05917
(2020)Doi:10.1002/zaac.19966220906
(1996)